Seeing Is Believing
Puma Biotechnology's activity chart (see below) currently has 21 price targets and 20 ratings on display.
Analysts average stock forecasts to be materialized ratio is 62.41% with an average time for these price targets to be met of 190.71 days.
Most recent stock forecast was given by from HC WAINWRIGHT on 28-Feb-2025. First documented stock forecast 02-Feb-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Dec-2019
$7
$-1.11 (-13.69%)
1 years 4 months 15 days ago
(28-Feb-2025)
16/17 (94.12%)
$3.42 (95.53%)
749
Hold Since 10-May-2019
$4
$-3.78 (-48.59%)
2 years 8 months 10 days ago
(03-Nov-2023)
2/7 (28.57%)
$1.22 (43.88%)
48
Sell Since 02-Nov-2018
$5
$-2.78 (-35.73%)
$6
4 years 8 months 8 days ago
(05-Nov-2021)
4/7 (57.14%)
$0.99 (24.69%)
296
Hold Since 07-Jun-2019
$11
$3.22 (41.39%)
$11
4 years 9 months 16 days ago
(27-Sep-2021)
14/23 (60.87%)
$3.88 (54.49%)
204
Hold Since 06-Dec-2018
$6
$-1.78 (-22.88%)
4 years 11 months 7 days ago
(06-Aug-2021)
8/9 (88.89%)
$-1.1 (-15.49%)
133
What is PBYI (Puma Biotechnology) average time for price targets to be met?
Which analyst has the current highest performing score on PBYI (Puma Biotechnology) with a proven track record?
Which analyst has the most public recommendations on PBYI (Puma Biotechnology)?
Which analyst is the currently most bullish on PBYI (Puma Biotechnology)?
Which analyst is the currently most reserved on PBYI (Puma Biotechnology)?